Form 4 Tracker
Xeris Biopharma Holdings, Inc.
XERS

19 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 1 8:51 PMBETH HECHT
Proposed Sale
49,998$7.92$396.0K

View →

Jul 1, 2026Jul 1 8:21 PMKEVIN MCCULLOCH
Proposed Sale
120,000$7.92$950.4K

View →

Jun 3, 2026Jun 5 10:29 PMMarla PerskyDirector
Sale
15,500$5.90$91.4K126,500(D)

View →

Jun 4, 2026Jun 5 10:18 PMDawn HalkuffDirector
Sale
20,000$6.09$121.9K95,000(D)

View →

Jun 4, 2026Jun 5 10:18 PMBarbara-Jean Anne Bormann-KennedyDirector
Sale
16,000$6.09$97.5K126,500(D)

View →

Jun 4, 2026Jun 5 10:17 PMJohn JohnsonDirector
Sale
15,000$6.09$91.4K683,083(D)

View →

Jun 4, 2026Jun 4 8:33 PMDAWN HALKUFF
Proposed Sale
20,000$5.89$117.8K

View →

Jun 4, 2026Jun 4 8:33 PMJOHN H JOHNSON
Proposed Sale
15,000$5.89$88.3K

View →

Jun 4, 2026Jun 4 8:32 PMBarbara-Jean Bormann-Kennedy
Proposed Sale
16,000$5.89$94.2K

View →

Jun 3, 2026Jun 3 8:25 PMMARLA PERSKY
Proposed Sale
15,500$6.00$93.0K

View →

Jun 1, 2026Jun 2 10:05 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$6.06$101.0K1,176,506(D)

View →

May 1, 2026May 1 9:50 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$6.23$103.8K1,193,173(D)

View →

Apr 1, 2026Apr 3 9:45 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$5.99$99.9K1,209,840(D)

View →

Mar 30, 2026Apr 1 9:54 PMJames Aloysius BradyDirector
Sale
10,834$5.54$60.0K89,166(D)

View →

Mar 30, 2026Mar 30 9:31 PMJAMES BRADY
Proposed Sale
10,834$5.40$58.5K

View →

Mar 2, 2026Mar 4 10:28 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$6.25$104.1K1,226,507(D)

View →

Mar 2, 2026Mar 2 9:36 PMBETH HECHT
Proposed Sale
66,668$6.12$408.0K

View →

Feb 2, 2026Feb 2 11:11 PMBeth HechtChief Legal Officer and Corporate Secretary
Sale
16,667$7.45$124.1K1,243,174(D)

View →

Jan 8, 2026Jan 8 9:22 PMKEVIN MCCULLOCH
Proposed Sale
60,000$7.21$432.6K

View →

Dec 19, 2025Dec 19 11:15 PMJOHN H JOHNSON
Proposed Sale
135,402$7.22$977.0K

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 5 10:39 PMGarheng KongDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:29 PMMarla PerskyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:18 PMDawn HalkuffDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:18 PMBarbara-Jean Anne Bormann-KennedyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:17 PMJohn JohnsonDirector
Grant/Award
32,996$6.1532,996(D)

View →

Jun 4, 2026Jun 5 10:16 PMJames Aloysius BradyDirector
Grant/Award
32,996$6.1532,996(D)

View →

Mar 12, 2026Mar 16 10:11 PMKevin MccullochPresident and Chief Operating Officer
Option Exercise
48,898$4.0979,996(D)

View →

Mar 5, 2026Mar 6 12:18 AMSteven PieperChief Financial Officer
Option Exercise
41,927$5.930(D)

View →

Jan 30, 2026Feb 2 11:13 PMJohn Patrick Shannon JrDirector, Chief Executive Officer and Director
Grant/Award
639,639$7.36639,639(D)

View →

Jan 30, 2026Feb 2 11:12 PMKevin MccullochPresident and Chief Operating Officer
Grant/Award
225,225$7.36225,225(D)

View →

Jan 30, 2026Feb 2 11:12 PMSteven PieperChief Financial Officer
Grant/Award
207,207$7.36207,207(D)

View →

Jan 30, 2026Feb 2 11:11 PMAnh Tu NguyenChief Medical Officer
Grant/Award
162,162$7.36162,162(D)

View →

Jan 30, 2026Feb 2 11:11 PMBeth HechtChief Legal Officer and Corporate Secretary
Grant/Award
162,162$7.36162,162(D)

View →